Bank Of America Corp Alnylam Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 631,112 shares of ALNY stock, worth $172 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

631,112

Previous 484,893 30.15%

Holding current value

$172 Million

Previous $72.5 Million 111.63%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$143.31 - $247.0 $21 Million - $36.1 Million	146,219 Added 30.15%	631,112 $153 Million
Q1 2024 May 15, 2024	BUY	$146.51 - $198.2 $24.7 Million - $33.4 Million	168,660 Added 53.33%	484,893 $72.5 Million
Q4 2023 Feb 14, 2024	SELL	$151.41 - $196.57 $5.47 Million - $7.1 Million	-36,110 Reduced 10.25%	316,233 $60.5 Million
Q2 2023 Aug 14, 2023	SELL	$185.01 - $212.05 $77.5 Million - $88.8 Million	-418,862 Reduced 54.31%	352,343 $66.9 Million
Q1 2023 May 12, 2023	BUY	$182.66 - $235.53 $85.5 Million - $110 Million	467,996 Added 154.35%	771,205 $154 Million
Q4 2022 Feb 10, 2023	BUY	$185.53 - $241.31 $12.1 Million - $15.8 Million	65,400 Added 27.5%	303,209 $72.1 Million
Q3 2022 Nov 14, 2022	SELL	$138.54 - $232.0 $594,059 - $994,816	-4,288 Reduced 1.77%	237,809 $47.6 Million
Q2 2022 Aug 12, 2022	SELL	$120.42 - $169.29 $4.23 Million - $5.95 Million	-35,160 Reduced 12.68%	242,097 $35.3 Million
Q1 2022 May 16, 2022	BUY	$127.18 - $173.91 $1.63 Million - $2.22 Million	12,779 Added 4.83%	277,257 $45.3 Million
Q4 2021 Feb 08, 2022	SELL	$159.56 - $209.29 $6.34 Million - $8.31 Million	-39,706 Reduced 13.05%	264,478 $44.8 Million
Q3 2021 Nov 15, 2021	BUY	$169.75 - $207.73 $238,159 - $291,445	1,403 Added 0.46%	304,184 $57.4 Million
Q2 2021 Sep 13, 2021	BUY	$128.63 - $176.89 $38.9 Million - $53.6 Million	302,781 New	302,781 $51.3 Million

Others Institutions Holding ALNY

# of Institutions

639

Shares Held

107M

Call Options Held

2.33M

Put Options Held

2.15M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $33.6B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Alnylam Pharmaceuticals, Inc. Transaction History